NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC portfolio value:
$854,000
portfolio value
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 122K | $688.87 | 1.24K | |
| Q2 2022 | share | Decrease | -23.21% | -375 shares | -395K | $591.13 | 1.24K |
| Q1 2022 | share | Decrease | -15.75% | -302 shares | -84K | $698.42 | 1.61K |
| Q4 2021 | share | 0.00% | 0 shares | 51K | $642.51 | 1.91K | |
| Q3 2021 | share | 0.00% | 0 shares | 90K | $605.18 | 1.91K | |
| Q2 2021 | share | Decrease | -11.49% | -249 shares | 45K | $558.54 | 1.91K |
| Q1 2021 | share | Decrease | -1.99% | -44 shares | -42K | $473.14 | 2.16K |
| Q4 2020 | share | Decrease | -4.41% | -102 shares | -226K | $483.11 | 2.21K |
| Q3 2020 | share | Increase | +12.50% | 257 shares | 12K | $559.78 | 2.31K |
| Q2 2020 | share | Decrease | -4.33% | -93 shares | 233K | $623.65 | 2.05K |
| Q1 2020 | share | Increase | +1.37% | 29 shares | 253K | $488.29 | 2.14K |
| Q4 2019 | share | 0.00% | 0 shares | 208K | $375.48 | 2.12K | |
| Q3 2019 | share | Increase | +6.64% | 132 shares | -35K | $277.4 | 2.12K |
| Q2 2019 | share | Increase | +3.76% | 72 shares | -164K | $313 | 1.98K |
| Q1 2019 | share | 0.00% | 0 shares | 71K | $410.62 | 1.91K | |
| Q4 2018 | share | 0.00% | 0 shares | -59K | $373.5 | 1.91K | |
| Q3 2018 | share | 0.00% | 0 shares | 113K | $404.04 | 1.91K | |
| Q2 2018 | share | Increase | +11.79% | 202 shares | 71K | $344.99 | 1.91K |
| Q1 2018 | share | Increase | +7.46% | 119 shares | -10K | $344.36 | 1.71K |
| Q4 2017 | share | Increase | +6280.00% | 1.57K shares | 589K | $375.96 | 1.59K |
| Q3 2017 | share | 0.00% | 0 shares | -1K | $447.12 | 25 | |
| Q2 2017 | share | 0.00% | 0 shares | 2K | $491.14 | 25 | |
| Q1 2017 | share | Increase | 0.00% | 25 shares | 10K | $387.51 | 25 |